Singapore mRNA vaccine developer raises $140m
RVAC Medicines, a Singapore-based company involved in developing messenger RNA (mRNA) vaccines for COVID-19, has closed a Series B round that takes its overall funding to USD 140m.
CBC Group, a China-focused healthcare GP that is looking to expand its coverage region-wide and is based in Singapore, incubated RVAC and led the Series B. Other participants included Temasek Holdings-owned...
More on Greater China
Latest News
HKEX relaxes rules for IPOs by pre-profit tech companies
The Hong Kong Stock Exchange (HKEX) has loosened its listing requirements to allow pre-profit technology companies to go public with market capitalisations as low as HKD 6bn (USD 764m).
Asia GPs must get smarter on target selection, costs - Bain & Co
Careful target selection – based on geography and sector – and increased emphasis on cost controls during ownership will be critical factors for Asian private equity investors as the industry braces for a downturn, according to Bain & Company.
Longreach buys Japan healthcare SaaS player
North Asia buyout specialist The Longreach Group has invested an undisclosed sum in Wellness Communications Corporation (WCC), a Japanese healthcare software-as-a-service (SaaS) provider.
Asia-Europe investor AGIC supports Danish electronics buyout
AGIC Capital, a specialist in Europe-China cross-border deals, has backed the acquisition of PR Electronics, a Danish manufacturer of signal processing equipment with an existing base in China.